Importantly, although less significant than its effect on G6PD, p52-ZER6 might also affect the expression of other glucose metabolism-related genes, such as FH, PKM2, TIGAR, LDHA, GLUT1, and HK2, thereby contributing to tumor metabolic reprogramming through multiple pathways. The gene discussed is LDHA; the disease is neoplasm.